The impact of drugs used in anaesthesia on bacteria

European Journal of Anaesthesiology

Volumn 16, Issue 7, 1999, Pages 425-440

  Batai I ^a,b   Kerenyi M ^b   Tekeres, M ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETOMIDATE; GLUCONATE CALCIUM; LOCAL ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; OPIATE; OXYGEN; PHENOTHIAZINE; PROPOFOL;

ANTIBACTERIAL ACTIVITY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM; BACTERIUM CONTAMINATION; POSTOPERATIVE INFECTION; REVIEW;

ANALGESICS; ANALGESICS, OPIOID; ANESTHESIA, INHALATION; ANESTHETICS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG CONTAMINATION; EQUIPMENT CONTAMINATION; HUMANS; SURGICAL WOUND INFECTION;

EID: 4243351590     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.1999.00498.x     Document Type: Review

References (129)

1. Rubin G. The influence of alcohol, ether, and chloroform on natural immunity in its relation to leucocytosis and phagocytosis. J Infect Dis 1904; 1: 425-444.
2. Gunzenhaeuser L, Mougdil GC, Mathieu A. Anaesthesia and the immune response. Baillière's Clin Anaesthesiol 1991; 5: 61-74.
3. Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992; 36: 201-220.
4. McBride WT, Armstrong MA, McBride SJ. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 1996; 51: 465-473.
5. Murray AE, Mostafa SM, van Saene HKF. Essentials in clinical microbiology. Baillière's Clin Anaesthesiol 1991; 5: 1-26.
6. Stoutenbeek CP, van Saene HKF. Infection prevention in intensive care by selective decontamination of the digestive tract. J Crit Care 1990; 5: 137-156.
7. Barana L, Gastaldo L, Maestri F et al. Postoperative infections. A prospective analysis of 1396 cases. Minerva Chir 1992; 47: 1177-1187.
8. Inglis TJJ, Lim EW, Lee GSH, Cheong KF, Ng KS. Endogenous source of bacteria in tracheal tube and proximal ventilator breathing system in intensive care patients. Br J Anaesth 1998; 80: 41-45.
9. Linton AH, Hinton MH. The normal microbiota of the body. In: Linton AH, Heather MD, eds. Topley and Wilson's Principles of Bacteriology, Virology and Immunity Volume 1, 8th Edn. London: Edward Arnold, 1990: 312-329.
10. Henderson B, Wilson M. Homo bacteriens and a network of surprises. J Med Microbiol 1996; 45: 393-394.
11. Henderson B, Wilson M. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 1996; 8: 269-282.
12. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60: 316-341.
13. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261.
14. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
15. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth 1997; 78: 201-219.
16. Sanders CC, Nelson GE, Sanders WE. Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A Streptococci. Infect Immun 1977; 16: 599-603.
17. Aitkenhead AR. Anaesthesia and the gastro-intestinal system. Eur J Anaesthesiol 1988; 5: 73-112.
18. Siboni K, Olsen H, Ravn E et al. Pseudomonas cepacia in 16 non-fatal cases of postoperative bacteremia derived from intrinsic contamination of the anaesthetic fentanyl. Scand J Infect Dis 1979; 11: 39-45.
19. Veber B, Gachot B, Bedos JP, Wolff M, Goodale DB. Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology 1994; 80: 712-713.
20. Blogg CE, Ramsay MA, Jarvis JD. Infection hazard from syringes. Br J Anaesth 1974; 46: 260-262.
21. Lessard MR, Trépanier CA, Gourdeau M, Denault PH. A microbiological study of the contamination of the syringes used in anaesthesia practice. Can J Anaesth 1988; 35: 567-569.
22. Sabon RL, Cheng EY, Stommel KA, Hennen CR. Glass particle contamination: Influence of aspiration methods and ampule types. Anesthesiology 1989; 70: 859-862.
23. Kempen PM, Treiber HS. Contamination of drugs in ampules - container as culprit! Anesth Analg 1990; 70: S197.
24. Zacher AN, Zornow MH, Evans G. Drug contamination from opening glass ampules. Anesthesiology 1991; 75: 893-895.
25. Kristiansen JE, Amaral L. The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 1997; 40: 319-327.
26. Bornisde GH, Cherry GW, Myeers MB. Intracolonic oxygen tension and in vivo bactericidial effect of hyperbaric oxygen on rat colonic flora. Aerospace Med 1973; 44: 1282-1286.
27. Center for Disease Control. Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent - California, Illinois, Maine, Michigan 1990. Morb Mortal Wkly Rep 1990; 39: 426-427.
28. Arduino MJ, Bland LA, McAllister SK et al. Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol 1991; 12: 535-539.
29. Daily MJ, Dickey JB, Packo KH. Endogenous endophthalmitis after intravenous anesthesia with propofol. Arch Ophthalmol 1991; 109: 1081-1084.
30. Tessler M, Dascal A, Gioseffini S, Miller M, Mendelson J. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media. Can J Anaesth 1992; 39: 509-511.
31. Bennett SN, McNeil MM, Bland LA et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333: 147-154.
32. Crowther J, Hrazdil J, Jolly DT, Galbraith JC, Greacen M, Grace M. Growth of microorganisms in propofol, thiopental, and 1: 1 mixture of propofol and thiopental. Anesth Analg 1996; 82: 475-478.
33. Graystone S, Wells MF, Farrell DJ. Do intensive care drug infusions support microbial growth? Anaesth Intensive Care 1997; 25: 640-642.
34. Berry CB, Gillespie T, Hood J, Scott NB. Growth of micro-organisms in solutions of intravenous anaesthetic agents. Anaesthesia 1993; 48: 30-32.
35. Langevin PB, Gulig PA, Gravenstein N, Langevin SO. A re-evaluation of the growth rate of Staphylococcus aureus in propofol and Intralipid: implications on infection. Anesth Analg 1995; 80: S263.
36. Langevin PB, Gulig PA, Gravenstein N, Bjoraker DG. Propofol: potentiation of infections. Anesthesiology 1993; 79[3A]: A1098.
37. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323: 301-308.
38. Gajraj RJ, Hodson MJ, Gillespie JA, Kenny GNC, Scott NB. Antibacterial activity of lidocaine in mixtures with Diprivan. Br J Anaesth 1998; 81: 444-448.
39. Quinn AC, Newman PJ, New LC, Grounds RM. Clinical significance of the growth of micro-organisms in propofol (letter). Anaesthesia 1993; 48: 923.
40. Farrington M, McGinnes J, Matthews I, Park GR. Do infusions of midazolam and propofol pose an infection risk to critically ill patients? Br J Anaesth 1994; 72: 415-417.
41. McHugh GJ, Roper GM. Propofol emulsion and bacterial contamination. Can J Anaesth 1995; 42: 801-804.
42. Bach A, Motsch J, Schmidt H et al. In-use contamination of propofol. A clinical study. Eur J Anaesthesiol 1997; 14: 178-183.
43. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 1993; 77: 766-768.
44. Wong CL, Warriner CB, McCormack JP, Clarke AM. Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks. Can J Anaesth 1992; 39: 504-508.
45. Eberhardt KE, Thimm BM, Spring A, Maskos WR. Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study. Infection 1992; 20: 12-18.
46. Lummis SC, Nicoletti G, Johnston GA, Holan G. Gamma-aminobutyric acid-modulated benzodiazepine binding sites in bacteria. Life Sci 1991; 49: 1079-1086.
47. Baker ME, Fanestil DD. Mammalian peripheral-type benzodiazepine receptor is homologous to CrtK protein of Rhodobacter capsulatus, a photosynthetic bacterium. Cell 1991; 65: 721-722.
48. Robertson MD, Drummer OH. Postmortem drug metabolism by bacteria. J Forensic Sci 1995; 40: 382-386.
49. Grimmond TR, Brownridge P. Antimicrobial activity of bupivacaine and pethidine. Anaesth Intensive Care 1986; 14: 418-420.
50. Rota S, Kaya K, Timlioolu Ö, Karaca Ö, Ýzdep S, Öcal E. Do the opioids have an antibacterial effect? Can J Anaesth 1997; 44: 679-680.
51. Simon EJ. Inhibition of bacterial growth by drugs of the morphine series. Sci 1964; 144: 543-544.
52. Zagon IS, McLaughlin PJ. An opioid growth factor regulates the replication of microorganisms. Life Sci 1992; 50: 1179-1187.
53. Maki DG, Klein BS, McCormick RD et al. Nosocomial Pseudomonas pickettii bacteremias traced to narcotic tampering. JAMA 1991; 265: 981-986.
54. Feldman JM, Chapin-Robertson K, Turner J. Do agents used for epidural analgesia have antimicrobial properties? Reg Anesth 1994; 19: 43-47.
55. Rosenberg PH, Renkonen OV. Antimicrobial activity of bupivacaine and morphine. Anesthesiology 1985; 62: 178-179.
56. Liras P, Kasparian SS, Umbreit WW. Enzymatic transformation of morphine by hydroxysteroid dehydrogenase from Pseudomonas testosteroni. Appl Microbiol 1975; 30: 650-656.
57. Bruce NC, Wilmot CJ, Jordan KN, Trebilcock AE, Stephens LDG, Lowe CR. Microbial degradation of the morphine alkaloids: identification of morphinone as an intermediate in the metabolism of morphine by Pseudomonas putida M10. Arch Microbiol 1990; 154: 465-470.
58. Hailes AM, Bruce NC. Biological synthesis of the analgesic hydromorphone, an intermediate in the metabolism of morphine, by Pseudomonas putida M10. Appl Environ Microbiol 1993; 59: 2166-2170.
59. Walsh CT, Levine RR. Studies of the enterohepatic circulation of morphine in the rat. J Pharmacol Exp Ther 1975; 195: 303-310.
60. Hawksworth G, Drasar BS, Hill MJ. Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol 1971; 4: 451-459.
61. Cabon F, Morser J, Parmantier E, Solly SK, Pham Dinh D, Zalc B. The E. coli envY gene encodes a high affinity opioid binding site. Neurochem Res 1993; 18: 795-800.
62. Waterhouse HF. A report on the employment of ether in surgical therapeusis. Br Med J 1915; 1: 233-237.
63. Topley WWC. The action of ether on certain microorganisms. Br Med J 1915; 1: 237-238.
64. Bray J. A method of suppressing proteus and coliform bacteria on routine blood agar plates. J Path Bact 1945; 57: 395-396.
65. Hutner SH, Bjerknes CK. Volatile preservatives for culture media. Proc Soc Exp Biol Med 1948; 67: 393-397.
66. Wardley-Smith B, Nunn JF. The effect of halothane on bacterial growth rate. Br J Anaesth 1971; 43: 919-925.
67. Barry PP, Paiement B, Dubeau M. Recherches sur l'activité antibactérienne de certains agents anesthésiques. Can Anaesth Soc J 1964; 11: 640-644.
68. Mehta S, Behr G, Kenyon D. The effect of volatile anaesthetics on bacterial growth. Can Anaesth Soc J 1973; 20: 230-240.
69. Slade JM. Bacterial growth in isoflurane vapour. Anaesthesia 1993; 48: 1053-1054.
70. Horton JN, Sussman M, Mushin WW. The antibacterial action of anaesthetic vapours. Br J Anaesth 1970; 42: 483-487.
71. Molliex S, Montravers P, Dureuil B, Desmonts JM. Halogenated anesthetics inhibit Pseudomonas aeruginosa growth in culture conditions reproducing the alveolar environment. Anesth Analg 1998; 86: 1075-1078.
72. Johnson BH, Eger IIEI. Bactericidal effects of anesthetics. Anesth Analg 1979; 58: 136-138.
73. Laverty DM, Fennema O. Effect of anaesthetics and dichlorodifluoromethane on the viability of the cells of Escherichia coli and the activities of some of its enzymes. Microbios 1985; 44: 7-20.
74. White DC, Dundas CR. Effect of anaesthetics on emission of light by luminous bacteria. Nature 1970; 226: 456-457.
75. Adey G, Dundas CR, White DC. The mechanism of anaesthesia: studies on the bacterial luminescent system in vitro. Br J Anaesth 1973; 45: 643.
76. Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors? Nature 1984; 310: 599-601.
77. Ormerod JG, Nesbakken T, Beale SI. Specific inhibition of antenna bacteriochlorophyll synthesis in Chlorobium vibrioforme by anesthetic gases. J Bacteriol 1990; 172: 1352-1360.
78. Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect 1990; 5: 173-184.
79. Graham EA. The influence of ether and ether anesthesia on bacteriolysis, agglutination, and phagocytosis. J Infect Dis 1911; 8: 147-175.
80. Bárdosi L, Bérdosi A, Hendrys M, Gabius HJ. Reduced expression of mannose-specific receptors on murine peripheral blood polymorphonuclear leukocytes following prolonged anaesthesia with different inhalation agents. Acta Anaesthesiol Scand 1990; 34: 286-290.
81. Ofek I, Mirelman D, Sharon N. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 1977; 265: 623-625.
82. Bátai I, Kerényi M, Tekeres M, Sarang K. Impact of halothane on bacterial adherence in vitro. Br J Anaesth 1995; 74 (Suppl. 1): 93.
83. Jonnesco T. Remarks on general spinal analgesia. Br Med J 1909; 2: 1396-1401.
84. Murphy JT, Allen HF, Mangiaracine AB. Preparation, sterilization, and preservation of ophthalmic solutions. Experimental studies and a practical method. Arch Ophthalmol 1955; 53: 63-78.
85. Erlich H. Bacteriologic studies and effects of anesthetic solutions on bronchial secretions during bronchoscopy. Am Rev Resp Dis 1961; 84: 414-421.
86. Conte BA, Laforet EG. The role of the topical anesthetic agent in modifying bacteriologic data obtained by bronchoscopy. N Engl J Med 1962; 267: 957-960.
87. Kleinfeld J, Ellis PP. Inhibition of microorganisms by topical anesthetics. Appl Microbiol 1967; 15: 1296-1298.
88. Wimberley N, Willey S, Sullivan N, Bartlett JG. Antibacterial properties of lidocaine. Chest 1979; 76: 37-40.
89. North JB, Brophy BP. Epidural abscess: a hazard of spinal epidural anaesthesia. Aust N Z J Surg 1979; 49: 484-485.
90. Miller MA, Shelley WB. Antibacterial properties of lidocaine on bacteria isolated from dermal lesions. Arch Dermatol 1985; 121: 1157-1159.
91. Zaidi S, Healy TEJ. A comparison of the antibacterial properties of six local analgesic agents. Anaesthesia 1977; 32: 69-70.
92. Fazly Bazaz BS, Salt WG. Local anaesthetics as antimicrobial agents: structure-action considerations. Microbios 1983; 37: 45-64.
93. Noda H, Saionji K, Miyazaki T. Antibacterial activity of local anesthetics. Masui 1990; 39: 994-1001.
94. Sakuragi T, Ishino H, Dan K. Bactericidal activity of clinically used local anesthetics on Staphylococcus aureus. Reg Anesth 1996; 21: 239-242.
95. James FM, George RH, Naiem H, White GJ. Bacteriologic aspects of epidural analgesia. Anesth Analg 1976; 55: 187-190.
96. Taki Y, Seki K, Ikigai H, Nishihara S, Ueno H, Murota K, Masuda S. Effect of temperature on antibacterial activity of lidocaine to Staphylococcus aureus and Pseudomonas aeruginosa. Microbiol Immunol 1988; 32: 429-434.
97. Weinstein MP, Maderazo E, Tilton R, Maggini G, Quintiliani R. Further observations on the antimicrobial effects of local anesthetic agents. Curr Ther Res 1975; 17: 369-374.
98. Ravin CE, Latimer JM, Matsen JM. In vitro effects of lidocaine on anaerobic respiratory pathogens and strains of Hemophilus influenzae. Chest 1977; 72: 439-441.
99. Schmidt RM, Rosenkranz HS. Antimicrobial activity of local anesthetics: lidocaine and procaine. J Infect Dis 1970; 121: 597-607.
100. Benson SA. Local anesthetics block induction of the Pseudomonas alk regulon. J Bacteriol 1979; 140: 1123-1125.
101. Tribhuwan RC, Pradhan DS. Induction of alkaline phosphatase in Escherichia coli. Effect of procaine hydrochloride. J Bacteriol 1977; 131: 431-437.
102. Lazdunski C, Pages J. Procaine, a local anesthetic interacting with the cell membrane, inhibits the processing of precursor forms of periplasmic proteins in Escherichia coli. Eur J Biochem 1979; 96: 49-57.
103. Gayda RC, Henderson GW, Markovitz A. Neuroactive drugs inhibit trypsin and outer membrane protein processing in Escherichia coli K-12. Proc Natl Acad Sci USA 1979; 76: 2138-2142.
104. Pugsley AP, Conrad DJ, Schnaitman CA, Gregg TI. In vivo effects of local anesthetics on the production of major outer membrane proteins by Escherichia coli. Biochim Biophys Acta 1980; 599: 1-12.
105. Granett S, Villarejo M. Selective inhibition of carbohydrate transport by the local anesthetic procaine in Escherichia coli. J Bacteriol 1981; 147: 289-296.
106. Silva MT, Sousa JCF, Polonia JJ, Macedo PM. Effects of local anesthetics on bacterial cells. J Bacteriol 1979; 137: 461-468.
107. Ohsuka S, Ohta M, Masuda K, Arakawa Y, Kaneda T, Kato N. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol Immunol 1994; 38: 429-434.
108. Fazly Bazaz BS, Salt WG. Local anaesthetics as antibacterial agents: effects on cellular respiration and the leakage of cytoplasmic constituents. Microbios 1983; 37: 139-149.
109. Tanji K, Mizushima T, Natori S, Sekimizu K. Induction by psychotropic drugs and local anesthetics of DnaK and GroEL proteins in Escherichia coli. Biochim Biophys Acta 1992; 1129: 172-176.
110. Leung YW, Rawal BD. Mechanism of action of tetracaine hydrochloride against Pseudomonas aeruginosa. J Infect Dis 1977; 136: 679-683.
111. Schmidt W, Schmidt H, Bauer H, Gebhard MM, Martin E. Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Anesthesiology 1997; 87: 617-624.
112. Clayton WP, Heggers JP, Shelton DF, Mendenhall MK. Viral and bacterial contamination of multiple-dose drug vials kept in anesthesia machines. Anesthesiology 1969; 30: 465-468.
113. Kerényi M, Bátai I, Kiss A, Tekeres M. Antimicrobial property of atracurium. 11th World Cong Anaesthesiologists 14-20 April 1996 Sydney, Australia. Abstract Book, 427 (P:735).
114. Highsmith AK, Greenhood GP, Allen JR. Growth of nosocomial pathogens in multiple-dose parenteral medication vials. J Clin Microbiol 1982; 15: 1024-1028.
115. Amaral L, Kristiansen JE, Lorian V. Synergic effect of chlorpromazine on the activity of some antibiotics. J Antimicrob Chemother 1992; 30: 556-558.
116. Molnár J, Haszon I, Bodrogi T, Martonyi E, Turi S. Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis. Int Urol Nephrol 1990; 22: 405-411.
117. Molnár J, Mándi Y, Király J. Antibacterial effect of some phenothiazine compounds and the R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 1976; 23: 45-54.
118. Molnár J, Mucsi I, Kása P. Inhibition of the adhesion of IX. coli cells in the presence of promethazine or imipramine. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983; 254: 388-396.
119. Krisriansen JEH. Experiments to illustrate the effect of chlorpromazine on the permeability of the bacterial cell wall. Acta Pathol Microbiol Scand Sect B 1979; 87: 317-319.
120. Amaral L, Lorian V. Effects of chlorpromazine on the cell envelope proteins of Escherichia coli. Antimicrob Agents Chemother 1991; 35: 1923-1924.
121. Amaral L, Kristiansen JE, Abebe L, Millett W. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J Antimicrob Chemother 1997; 38: 1049-1053.
122. Crowle AJ, Douvas GS, May MH. Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Chemotherapy 1992; 38: 410-419.
123. Spalter J, Jackson M, Matz R. Bacteria in medications. Growth during emergency resuscitation. NY State J Med 1976; 76: 693-694.
124. Bétai I, Kerényi M, Kiss A, Tekeres M. Growth of microorganisms in intravenous nitrates or in sodium nitroprusside. Anesth Analg 1997; 84: S467.
125. Giunta S, Galeazi L, Turchetti G, Sampaoli G, Groppa G. In vitro antistreptococcal activity of the potassium sparing diuretics amiloride and triamterene. Antimicrob Agents Chemother 1985; 28: 419-420.
126. Domenico P, Schwartz S, Cunha BA. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989; 57: 3778-3782.
127. Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol 1977; 5: 58-61.
128. Takahashi N, Murota H, Sutoh I. Antimicrobial activity of topical beta-adrenergic blocking agents. Ophthalmic Res 1983; 15: 277-279.
129. Cederlund H, Mårdh P. Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 1993; 32: 355-365.